Evidence map›Paper›PMID 32855533›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm.

Sandy Elbitar, Marjolijn Renard, Pauline Arnaud, Nadine Hanna, Marie-Paule Jacob, Dong-Chuan Guo, Ko Tsutsui, Marie-Sylvie Gross, Ketty Kessler, Laurent Tosolini and 25 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Physiology (Bethesda, Md.) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Genome-Wide Association Study of Immune Indices in Yaks.Animals : an open access journal from MDPI · 2025
    Article
  10. Article
  11. ProteinMolecules (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Worldwide study of the taste of bitter medicines and their modifiers.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 12 institutions in 7 countries.

Sandy Elbitar *Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Marjolijn Renard *Center for Medical Genetics, Ghent University, Ghent, Belgium.
Pauline ArnaudLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Nadine HannaLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Marie-Paule JacobLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Dong-Chuan GuoDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Ko TsutsuiInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.
Marie-Sylvie GrossLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Ketty KesslerCentre for Evolution and Cancer, Division of Molecular Pathology, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Laurent TosoliniLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Vincenzo DattiloIRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Sebastien DupontLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Jeremie JonquetLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Maud LangeoisHospitalo-Universitaire Xavier Bichat, APHP, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Paris, France.
Louise BenarrochLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Melodie AubartLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Youmna GhalebLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Yara Abou KhalilLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Mathilde VarretLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Petra El KhouryLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Benoit Ho-Tin-NoéLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Yves AlembikDepartment of Clinical Genetic, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Sébastien GaertnerDepartment of Hypertension, Vascular Diseases and Pharmacology, University of Strasbourg, Strasbourg, France.
Bertrand IsidorService de Génétique Médicale, Hôpital Hôtel-Dieu, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Laurent GouyaHospitalo-Universitaire Xavier Bichat, APHP, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Paris, France.
Olivier MilleronHospitalo-Universitaire Xavier Bichat, APHP, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Paris, France.
Kiyotoshi SekiguchiInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.
Dianna MilewiczDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Julie De BackerCenter for Medical Genetics, Ghent University, Ghent, Belgium.
Carine Le GoffLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Jean-Baptiste MichelLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Guillaume JondeauLaboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
Lynn Y SakaiShriners Hospital for Children, Molecular & Medical Genetics and Biochemistry & Molecular Biology, Oregon Health & Science University, Portland, OR, USA.
Catherine Boileau *Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France. catherine.boileau@inserm.fr.
Marianne Abifadel *Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France. marianne.abi-fadel@inserm.fr.ORCID http://orcid.org/0000-0001-7645-8323
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRGhent University Hospital · BEHôpital Necker-Enfants Malades · FRProtein Research Foundation · JPThe University of Texas Health Science Center at Houston · USCentre Hospitalier Universitaire de Nantes · FRCentro San Giovanni di Dio Fatebenefratelli · ITHôpitaux Universitaires de Strasbourg · FRInstitute of Cancer Research · GBOregon Health & Science University · USUniversité de Strasbourg · FR

Funding

Genetic Predisposition To Thoracic Aortic Aneurysms/DissectionsR01HL109942 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2023
$7.5M
NHLBI NIH HHS R01 HL109942
6 · The paper itself

Abstract

purposeThoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease with often unrecognized inherited forms. We sought to identify novel pathogenic variants associated with autosomal dominant inheritance of TAAD.

methodsWe analyzed exome sequencing data from 35 French TAAD families and performed next-generation sequencing capture panel of genes in 1114 unrelated TAAD patients. Functional effects of pathogenic variants identified were validated in cell, tissue, and mouse models.

resultsWe identified five functional variants in THSD4 of which two heterozygous variants lead to a premature termination codon. THSD4 encodes ADAMTSL6 (member of the ADAMTS/L superfamily), a microfibril-associated protein that promotes fibrillin-1 matrix assembly. The THSD4 variants studied lead to haploinsufficiency or impaired assembly of fibrillin-1 microfibrils. Thsd4

conclusionThese findings highlight the role of ADAMTSL6 in aortic physiology and TAAD pathogenesis. They will improve TAAD management and help develop new targeted therapies.

Indexed as

Aortic Aneurysm, ThoracicAortic DissectionADAM ProteinsAnimalsExomeFibrillin-1HumansMiceADAM ProteinsFibrillin-1ADAMTSL6diagnosisthoracic aortic aneurysmTHSD4

Identifiers

PMID32855533
PMCPMC8559271
OpenAlexW3082438439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.